Reference 14 - Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage
NonrulemakingSupporting & Related MaterialFDA-2026-P-6541-0016
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 9, 2026
- Agency
- Food and Drug Administration (FDA)